We want to ensure that we can make prevention work for you, which is why we offer you tools that allow you to evaluate the success and sustainability of prevention.
BECAL (The Boehringer Ingelheim Economic Calculator) was created in collaboration with industry experts to provide a convenient tool for the economic analysis of vaccination interventions. The tool evaluates preventative health measures by easily calculating return on investment and benefit-cost ratios based on your production data. BECAL enables effective and proactive planning to help you to shape the future of swine health.
PRRS control is much more than just vaccination alone. It requires a comprehensive understanding of the disease and the production system under threat, the use of multiple management tools, and a systematic approach to management.
BECAL (The Boehringer Ingelheim Economic Calculator) was created in collaboration with industry experts to provide a convenient tool for the economic analysis of vaccination interventions. BECALsow looks at health interventions in the sow herd and evaluates preventative health measures by easily calculating the return of investment based on production data.
During the last fifty years or so, disease control in the pork industry has evolved mainly relying on antimicrobials, vaccines, elimination (depopulation, repopulation, eradication, modified early weaning), and/or regional control depending on the diseases of concern and resources available. Looking forward, it is clear that antimicrobial usage, under increasing scrutiny for both metaphylactic and therapeutic uses will decline, whereas the use of vaccines will likely rise.
ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health. ARTES Biotechnology specialises in recombinant protein production, process and vaccine development from microbial expression systems. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ METAVAX® platform, this offers a new, unique and economical approach to low-cost mass production of safe and effective vaccines required in the veterinary field.
Get the latest news on Swine Health Subscribe to our newsletter
